← FDA DRUG APPROVALS

FDA ANDA · ANDA210597

METOPROLOL SUCCINATE

Sponsor: PRINSTON INC

APPLICATION
ANDA210597
TYPE
ANDA
ORIGINAL APPROVAL
2022-01-04
LATEST ACTION
2025-07-10
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 200MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 100MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL

Approval history

2025-07-10Labeling · Supplement 2 · standardAP
2023-05-08Labeling · Supplement 1 · standardAP
2022-01-04UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →